Is it Time to Update cGMPs?

September 15, 2019
Agnes Shanley

Agnes Shanley is senior editor of BioPharm International.

BioPharm International, BioPharm International-09-15-2019, Volume 2019 eBook, Issue 3
Pages: 10–13

Industry practice has changed radically over the past five decades. Can laws published in the 1960s still ensure pharmaceutical quality and safety today?

The biopharmaceutical industry has undergone major changes since GMPs were last updated in 1977. However, FDA says it has no plans for any major revisions of cGMPs. Industry experts argue, however, that changes are needed in Training and employee personal development, statistics and sampling, and process validation.

 

Read this article in BioPharm International’s September 2019 Regulatory Sourcebook.

 

Article Details

BioPharm International
eBook: Regulatory Sourcebook, September 2019
September 2019
Pages: 10–13

Citation

When referring to this article, please cite it as A. Shanley, “Is it Time to Update cGMPs?" BioPharm International Regulatory Sourcebook eBook (September 2019).